Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON52303
NL-OMON52303
Recruiting
Not Applicable

A prospective cohort study evaluating the occurrence of short and long-term cardiovascular complications in patients hospitalized with COVID-19 - CAPACITY 2

niversitair Medisch Centrum Utrecht0 sites500 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionscardiac abnormalitiescardiac complications1008220610014523

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
cardiac abnormalities
Sponsor
niversitair Medisch Centrum Utrecht
Enrollment
500
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
niversitair Medisch Centrum Utrecht

Eligibility Criteria

Inclusion Criteria

  • •Age \>\=18 and \<70 years
  • •A PCR confirmed infection with SARS\-CoV\-2 \<48h of admission
  • •Treatment of COVID\-19 is the primary reason of hospitalization
  • •The patient was independent in ADL prior to admission
  • •The patient or proxy (close relative) is capable of giving informed consent
  • •To be included in the healthcare pathway group, at least two of the following
  • •additional criteria should be met within 48h of admission:
  • •Troponin levels \>4x ULN
  • •New ECG abnormalities including repolarization abnormalities, arrhythmia,
  • •signs of right ventricular strain, axis deviation, dynamic ECG changes or any

Exclusion Criteria

  • •Anticipated) in\-hospital stay \<48h
  • •First admission for COVID\-19 took place in another hospital and the patient
  • •was transferred to the current hospital \>48h after first admission
  • •Recent (\<6 months) cardiac pathology prior to hospital admission including:
  • •o Myocardial infarction or unstable angina
  • •o Decompensated heart failure that required hospital admission
  • •o Uncontrolled ventricular arrhythmia
  • •o Percutaneous coronary intervention, CABG, valvular replacement or any other
  • •major cardiac surgery
  • •o Cardiac device implantation

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
A Prospective Cohort Study Evaluating the Incidence of NephrogenicSystemic Fibrosis in Patients with Stages 3 to 5 Chronic Kidney DiseaseUndergoing MRI with the Injection of ProHance - Evaluation of the Incidence of NSF Following ProHance Injectio
EUCTR2007-003589-16-FRBracco Imaging S.p.A.1,000
Not yet recruiting
Not Applicable
A prospective cohort study evaluating the incidence of and outcomes associated with dose reductions of diabetic medications in a population of older inpatients discharged to a nursing homeDiabetes
ACTRN12617000114347Flinders Medical Centre100
Active, not recruiting
Not Applicable
A PROSPECTIVE COHORT STUDY EVALUATING THE INCIDENCE OF NEPHROGENIC SYSTEMIC FIBROSIS IN PATIENTS WITH STAGES 3 TO 5 CHRONIC KIDNEY DISEASE UNDERGOING MRI WITH THE INJECTION OF PROHANCE - Evaluation of the Risk of NSF Following ProHance InjectioSafety of Contrast enhanced MRI diagnoses in patients suffering from some chronic kidney disease stage 3 (cohort 1) or stage 4 to 5 (cohort 2)MedDRA version: 9.1Level: LLTClassification code 10029820MedDRA version: 9.1Level: SOCClassification code 10038359
EUCTR2007-003589-16-ITBRACCO IMAGING1,000
Not yet recruiting
Not Applicable
This is a type of cancer found in elderly patients
CTRI/2022/09/045751Investigator initiated trial
Recruiting
Not Applicable
A study to see what proportion of patients of acute pancreatitis develop vascular complications and how the vascular complications evolve and what is their outcomeHealth Condition 1: K859- Acute pancreatitis, unspecified
CTRI/2020/05/025024Department of Gastroenterology IPGMER AND SSKM HOSPITA